In 1995, Mark Keating and colleagues identified two genes responsible for congenital long QT syndrome, a cause of sudden cardiac death. Perturbations in the ion channels that orchestrate the beating heart were central to the disorder. This revelation provided a molecular model for the study of ventricular arrhythmias and enabled further dissection of the genetic defects underlying subtleties in the cardiac phenotype. Soon, these discoveries will be further translated to clinical medicine, with the expected release of one of the first comprehensive clinical genetic tests in cardiology.
References
Ackerman, M.J. & Clapham, D.E. N. Engl. J. Med. 336, 1575–1586 (1997).
Curran, M.E. et al. Cell 80, 795–803 (1995).
Wang, Q. et al. Cell 80, 805–811 (1995).
Keating, M. et al. Science 252, 704–706 (1991).
Warmke, J.W. & Ganetzky, B. Proc. Natl. Acad. Sci. USA 91, 3438–3442 (1994).
Sanguinetti, M.C., Jiang, C., Curran, M.E. & Keating, M.T. Cell 81, 299–307 (1995).
Wang, Q. et al. Nat. Genet. 12, 17–23 (1996).
Splawski, I., Timothy, K.W., Vincent, G.M., Atkinson, D.L. & Keating, M.T. N. Engl. J. Med. 336, 1562–1567 (1997).
Moss, A.J., Schwartz, P.J., Crampton, R.S., Locati, E. & Carleen, E. Circulation 71, 17–21 (1985).
Splawski, I., Tristani-Firouzi, M., Lehmann, M.H., Sanguinetti, M.C. & Keating, M.T. Nat. Genet. 17, 338–340 (1997).
Abbott, G.W. et al. Cell 97, 175–187 (1999).
Mohler, P.J. et al. Nature 421, 634–639 (2003).
Chen, Y.-H. et al. Science 299, 251–254 (2003).
Brugada, R. et al. Circulation 109, 30–35 (2004).
Chen, Q. et al. Nature 392, 293–296 (1998).
Schott, J.-J. et al. Nat. Genet. 23, 20–21 (1999).
Benson, D.W. et al. J. Clin. Invest. 112, 1019–1028 (2003).
Ackerman, M.J. et al. J. Am. Med. Assoc. 286, 2264–2269 (2001).
Yang, P. et al. Circulation 105, 1943–1948 (2002).
Splawski, I. et al. Science 297, 1333–1336 (2002).
Moss, A.J. et al. Circulation 92, 2929–2934 (1995).
Ackerman, M.J. et al. Mayo Clin. Proc. 77, 413–421 (2002).
Schwartz, P.J. et al. Circulation 103, 89–95 (2001).
Moss, A.J. et al. Circulation 101, 616–623 (2000).
Priori, S.G. et al. N. Engl. J. Med. 348, 1866–1874 (2003).
Genaissance Pharmaceuticals, Inc. Press Release. Genaissance Pharmaceuticals Signs Agreements to Support its Development of Tests for Sudden Cardiac Death Syndromes. PR Newswire (April 6, 2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ackerman, M. Cardiac channelopathies: it's in the genes. Nat Med 10, 463–464 (2004). https://doi.org/10.1038/nm0504-463
Issue Date:
DOI: https://doi.org/10.1038/nm0504-463
- Springer Nature America, Inc.
This article is cited by
-
Generationenübergreifende Betreuung von Patienten mit tachykarden Rhythmusstörungen
Monatsschrift Kinderheilkunde (2022)
-
QTc interval-dependent body posture in pediatrics
BMC Pediatrics (2020)
-
Genetic innovations and our understanding of stillbirth
Human Genetics (2020)
-
Enhancing the Predictive Power of Mutations in the C-Terminus of the KCNQ1-Encoded Kv7.1 Voltage-Gated Potassium Channel
Journal of Cardiovascular Translational Research (2015)